TerminatedNot applicableNCT00272766
Macugen for Histoplasmosis
Studying Histoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Barnes Retina Institute
- Principal Investigator
- Gaurav K Shah, MDBarnes Retina Institute
- Intervention
- pegaptanib sodium(drug)
- Enrollment
- 24 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2006 – 2007
Study locations (1)
- Barnes Retina Institute, St Louis, Missouri, United States
Collaborators
Pfizer
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00272766 on ClinicalTrials.govOther trials for Histoplasmosis
Additional recruiting or active studies for the same condition.